Biotechnology The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of ARQQ, AXSM and CDNA June 2, 2022
Biotechnology Axsome Therapeutics Presents New Data from the GEMINI Trial Demonstrating Efficacy of AXS-05 on Anhedonia in Patients with Major Depressive Disorder June 2, 2022
Biotechnology GBT to Host Investor Conference Call on Friday, June 10 and Participate in Upcoming Investor Conferences June 1, 2022